Rankings
▼
Calendar
CBIO FY 2015 Earnings — Crescent Biopharma, Inc. Revenue & Financial Results | Market Cap Arena
CBIO
Crescent Biopharma, Inc.
$327M
FY 2015 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$20M
+33.6% YoY
Gross Profit
$20M
100.0% margin
Operating Income
-$13M
-63.7% margin
Net Income
-$13M
-63.6% margin
EPS (Diluted)
$-0.67
Cash Flow
Operating Cash Flow
-$8M
Free Cash Flow
-$9M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$48M
Total Liabilities
$8M
Stockholders' Equity
$40M
Cash & Equivalents
$47M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$20M
$15M
+33.6%
Gross Profit
$20M
$15M
+33.6%
Operating Income
-$13M
-$11M
-14.8%
Net Income
-$13M
-$11M
-14.8%
← FY 2014
All Quarters
Q1 2016 →